Supplemental material
OncoImmunology
Volume 2, 2013 - Issue 11
Related Research Data
Malignant effusions and immunogenic tumour-derived exosomes
Source:
Elsevier BV
Identification of multiple antigens recognized by tumor-infiltrating lymphocytes from a single patient: tumor escape by antigen loss and loss of MHC expression.
Source:
Ovid Technologies (Wolters Kluwer Health)
Selective expression of an antigen receptor on CD8-bearing T lymphocytes in transgenic mice.
Source:
Springer Science and Business Media LLC
Synergy between T-cell immunity and inhibition of paracrine stimulation causes tumor rejection.
Source:
Proceedings of the National Academy of Sciences
Immunosuppressive Strategies that are Mediated by Tumor Cells
Source:
Annual Reviews
Fibroblasts in cancer
Source:
Springer Science and Business Media LLC
Membrane vesicles as conveyors of immune responses
Source:
Springer Science and Business Media LLC
Tumour ischaemia by interferon-γ resembles physiological blood vessel regression
Source:
Springer Science and Business Media LLC
Production of high titer helper-free retroviruses by transient transfection
Source:
Proceedings of the National Academy of Sciences
Cytotoxic immunological synapses do not restrict the action of interferon-γ to antigenic target cells
Source:
Proceedings of the National Academy of Sciences
The color of mice: In the light of GFP-variant reporters
Source:
Springer Science and Business Media LLC
Simultaneous measurement of RBC velocity, flux, hematocrit and shear rate in vascular networks
Source:
Springer Science and Business Media LLC
Bystander elimination of antigen loss variants in established tumors.
Source:
Springer Science and Business Media LLC
Induced sensitization of tumor stroma leads to eradication of established cancer by T cells
Source:
Rockefeller University Press
An improved cyan fluorescent protein variant useful for FRET.
Source:
Springer Science and Business Media LLC
Targeting the tumour stroma to increase efficacy of chemo- and radiotherapy
Source:
Springer Science and Business Media LLC
Equilibrium between Host and Cancer Caused by Effector T Cells Killing Tumor Stroma
Source:
American Association for Cancer Research (AACR)
Tumor necrosis factor: a potent effector molecule for tumor cell killing by activated macrophages.
Source:
Proceedings of the National Academy of Sciences
Multiphoton imaging of cytotoxic T lymphocyte-mediated antitumor immune responses.
Source:
Springer Berlin Heidelberg
Fas expression by tumor stroma is required for cancer eradication
Source:
Proceedings of the National Academy of Sciences
Myeloid suppressor cells in cancer: recruitment, phenotype, properties, and mechanisms of immune suppression.
Source:
Elsevier BV
Noninvasive visualization of tumors in rodent dorsal skin window chambers.
Source:
Springer Science and Business Media LLC
Erratum: Mouse in red - red fluorescent protein expression in mouse ES cells, embryos and adult animals (Genesis)
Source:
Wiley
Random migration precedes stable target cell interactions of tumor-infiltrating T cells
Source:
Rockefeller University Press
Tumour-associated macrophages are a distinct M2 polarised population promoting tumour progression: Potential targets of anti-cancer therapy
Source:
Elsevier BV
Shedding microvesicles: artefacts no more
Source:
Elsevier BV
Linking provided by
